Sweden’s radiation regulator has approved continued operation of Forsmark 3 until 2033 after a safety review under new ...

Editor’s note: This article is published after the passing away of Dan Hirsch. The draft manuscript was prepared by all authors. It has been lightly edited for style, length, and clarity. In May, ...

Dubai: In a groundbreaking step that reinforces Dubai’s position as a global hub for safe trade, Dubai Customs has unveiled its “Radiation Protection and Monitoring System” during its participation in ...

This IAEA Safety Report describes neutron monitoring procedures and equipment that may be used for radiation protection in nuclear power production, medical and industrial applications, research ...

The interstellar comet 3I/ATLAS has a thick irradiated crust that no longer resembles its home star system, simulations and James Webb Space Telescope observations have found.

Canada and the United States phased out lead paint decades ago due to serious health risks, but social media users are now ...

WASHINGTON (AP) — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving ...

The Bioeconomy Science Institute says genetic experiments on large animals stopped because its specialised facility near Hamilton closed in late June. Photo / Lucy Penellum The newly-formed Bioeconomy ...

NEW YORK/PARIS, Oct 8 (Reuters) - A race by crypto companies to sell tokens pegged to stocks is raising alarm bells among traditional financial firms and regulatory experts who warn that the ...

WASHINGTON (AP) — Former President Joe Biden on Monday completed a round of radiation therapy treatment for the aggressive form of prostate cancer he was diagnosed with after leaving office, a ...

Written to assist the implementation in medical imaging practice of the requirements of the IAEA Safety Standards Series No. GSR Part 3, Radiation Protection and Safety of Radiation Sources: ...

On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients ...